Stock comparison
JOHNSON & JOHNSON is 15.7x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($663.28 B vs $42.34 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 15.7x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($663.28 B vs $42.34 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 15.7x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($663.28 B vs $42.34 B).
Revenue leader
JNJ
TEVA: $17.26B vs JNJ: $94.19B.
Profit leader
JNJ
TEVA: $1.41B vs JNJ: $26.80B.
Margin leader
JNJ
TEVA: 8.2% vs JNJ: 28.5% net margin.
| Metric | TEVA | JNJ |
|---|---|---|
| Market cap | $42.34 B | $663.28 B |
| US-listed rank | #371 | #16 |
| Revenue (latest FY) | $17.26B | $94.19B |
| Net income (latest FY) | $1.41B | $26.80B |
| Net margin | 8.2% | 28.5% |
| P/E (trailing FY) | 30.0x | 24.7x |
| SEC filings | 2,476 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 15.7x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($663.28 B vs $42.34 B).
In their latest fiscal years, TEVA PHARMACEUTICAL INDUSTRIES LTD reported $17.26B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: TEVA PHARMACEUTICAL INDUSTRIES LTD and JOHNSON & JOHNSON, or browse the full rankings.